Keywords: merck, serono, buys, bionomics, ms, drug, licensing

Merck Serono buys Bionomics MS drug

Article | 30 June 2008

Print This

In a licensing and development deal with Australia's Bionomics, Switzerland-based Merck Serono, part of German drug major Merck KGaA, has ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in